Another team used high concentrations of the ACAT1 inhibitor F12511 encapsulated in stealth liposomes to significantly improve amyloid pathology in aged 3xTg AD mice, reducing hyperphosphorylated tau and non-phosphorylated tau, as well as alleviating neuroinflammation [110]. This evidence concerns the gene MAPT and Alzheimer disease.